Search research articles
Contact Us
Filters
Showing results (121-130 of 259) with videos related to
Page
of 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2020
Differential Benefit of Adjuvant Docetaxel-Based Chemotherapy in Patients With Early Breast Cancer According to Baseline Body Mass Index
Christine Desmedt, Marco Fornili, Florian Clatot, et al.
BMJ Supportive & Palliative Care
|
December 18, 2020
Malignant bowel obstruction: effectiveness and safety of systemic chemotherapy
Rafael Caparica, Larissa Amorim, Paulo Amaral, et al.
Cancer Treatment Reviews
|
November 29, 2024
Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer
Volkmar Müller, Thomas Bachelot, Giuseppe Curigliano, et al.
Journal of Cancer Research and Clinical Oncology
|
July 22, 2022
Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis
Diogo Martins-Branco, Guilherme Nader-Marta, Ana Tecic Vuger, et al.
Journal of the National Cancer Institute
|
March 31, 2021
Tumor Cellularity and Infiltrating Lymphocytes as a Survival Surrogate in HER2-Positive Breast Cancer
Nuria Chic, Stephen J Luen, Paolo Nuciforo, et al.
Breast Cancer Research and Treatment
|
December 29, 2015
Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience
Otto Metzger-Filho, Evandro de Azambuja, Marion Procter, et al.
Breast Cancer Research and Treatment
|
October 13, 2019
A pooled analysis of the cardiac events in the trastuzumab adjuvant trials
Evandro de Azambuja, Noam Ponde, Marion Procter, et al.
AIDS (London, England)
|
January 4, 2021
Impact of HIV infection on baseline characteristics and survival of women with breast cancer
Mariana Brandão, Marco Bruzzone, Maria-Alice Franzoi, et al.
Journal of the National Cancer Institute
|
April 4, 2026
The benefit of adjuvant pertuzumab and trastuzumab according to estrogen receptor and HER2 expression: a Sub-analysis of the APHINITY trial
Elisa Agostinetto, Gabriella Gentile, Faye Samy, et al.
International Journal of Cancer
|
November 5, 2020
STAT3 activation in HER2-positive breast cancers: Analysis of data from a large prospective trial
Amir Sonnenblick, Dominique Agbor-Tarh, Evandro de Azambuja, et al.
Page
of 26
Search research articles
Search
Showing results (121-130 of 259) with videos related to
Sort By:
Page
of 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 3, 2020
Differential Benefit of Adjuvant Docetaxel-Based Chemotherapy in Patients With Early Breast Cancer According to Baseline Body Mass Index
Christine Desmedt, Marco Fornili, Florian Clatot, et al.
BMJ Supportive & Palliative Care
|
December 18, 2020
Malignant bowel obstruction: effectiveness and safety of systemic chemotherapy
Rafael Caparica, Larissa Amorim, Paulo Amaral, et al.
Cancer Treatment Reviews
|
November 29, 2024
Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer
Volkmar Müller, Thomas Bachelot, Giuseppe Curigliano, et al.
Journal of Cancer Research and Clinical Oncology
|
July 22, 2022
Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis
Diogo Martins-Branco, Guilherme Nader-Marta, Ana Tecic Vuger, et al.
Journal of the National Cancer Institute
|
March 31, 2021
Tumor Cellularity and Infiltrating Lymphocytes as a Survival Surrogate in HER2-Positive Breast Cancer
Nuria Chic, Stephen J Luen, Paolo Nuciforo, et al.
Breast Cancer Research and Treatment
|
December 29, 2015
Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience
Otto Metzger-Filho, Evandro de Azambuja, Marion Procter, et al.
Breast Cancer Research and Treatment
|
October 13, 2019
A pooled analysis of the cardiac events in the trastuzumab adjuvant trials
Evandro de Azambuja, Noam Ponde, Marion Procter, et al.
AIDS (London, England)
|
January 4, 2021
Impact of HIV infection on baseline characteristics and survival of women with breast cancer
Mariana Brandão, Marco Bruzzone, Maria-Alice Franzoi, et al.
Journal of the National Cancer Institute
|
April 4, 2026
The benefit of adjuvant pertuzumab and trastuzumab according to estrogen receptor and HER2 expression: a Sub-analysis of the APHINITY trial
Elisa Agostinetto, Gabriella Gentile, Faye Samy, et al.
International Journal of Cancer
|
November 5, 2020
STAT3 activation in HER2-positive breast cancers: Analysis of data from a large prospective trial
Amir Sonnenblick, Dominique Agbor-Tarh, Evandro de Azambuja, et al.
Page
of 26